反应详情

1-(3,4-Methylenedioxyphenyl)-2-benzyl-2,3,4,9-tetrahydro-1H-β-carboline (0.79 g, 2.0 mmol) (prepared as in Example 1) was dissolved in dry DMF (15 mL). Potassium t-butoxide (0.56 g, 5.0 mmol) was added, followed by oxygen, bubbled in via syringe needle. The mixture was maintained at room temperature for one hour and then poured onto a mixture of 1N HCl (5 mL), water (35 mL) and ethyl acetate (35 mL). A fluffy yellow precipitate was collected, the organic layer removed, and the aqueous solution extracted with ethyl acetate (15 mL). The extracted layer was agitated and set aside overnight. The following day an additional quantity of product (as a precipitate) was collected. Drying of the combined solids yielded the product as a yellow powder.

1. custombubbled in via syringe needle
2. additionpoured onto a mixture of 1N HCl (5 mL), water (35 mL) and ethyl acetate (35 mL)
3. customA fluffy yellow precipitate was collected
4. customthe organic layer removed
5. extractionthe aqueous solution extracted with ethyl acetate (15 mL)
6. customThe following day an additional quantity of product (as a precipitate) was collected
7. customDrying of the combined solids